Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance

About us

ENCePP aims to strengthen the monitoring of the benefit-risk balance of medicinal products in Europe by:

  • Facilitating the conduct of high quality, multi-centre, independent post-authorisation studies (PAS) with a focus on observational research;
  • Bringing together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe and providing a platform for collaborations;
  • Developing and maintaining methodological standards and governance principles for research in pharmacovigilance and pharmacoepidemiology.

ENCePP provides a unique opportunity for collaboration to improve pharmacoepidemiological research and post-authorisation safety surveillance of medicinal products in Europe through access to a network of resources working in a transparent and independent manner and support to conduct joint studies.

Since its establishment ENCePP has produced a number of key outputs:

  • Previous ENCePP Database of Research Resources. The data sources, institutions and networks are available in the EMA-HMA Catalogues.
  • ENCePP Code of Conduct: a set of rules and principles for pharmacoepidemiology and pharmacovigilance studies to promote transparency and scientific independence throughout the research process